When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Humanigen (OTCQB:HGEN) has submitted a protocol synopsis to the FDA related to its planned Phase 3 study of lenzilumab for the prevention and treatment of cytokine storm in COVID-19 patients.
More news on: Humanigen, Inc., Hoth Therapeutics, Inc., Allogene Therapeutics, Inc., Healthcare stocks news, Stocks on the move,